Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
11,867
Total Claims
$1.2M
Drug Cost
534
Beneficiaries
$2,212
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
+96%
Opioid rate vs peers
5.1% vs 2.6% avg
+107%
Cost per patient vs peers
$2,212 vs $1,068 avg
+45%
Brand preference vs peers
13.0% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
5.1%
Opioid Rate
601
Opioid Claims
$13K
Opioid Cost
3.0%
Long-Acting Rate
Brand vs Generic
Brand: 1,527 claims · $961K
Generic: 10,194 claims · $212K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 68 | $117K |
| Apixaban | 123 | $117K |
| Semaglutide | 79 | $106K |
| Empagliflozin | 67 | $67K |
| Tirzepatide | 46 | $54K |
| Insulin Aspart | 55 | $42K |
| Insulin Detemir | 37 | $31K |
| Semaglutide | 21 | $28K |
| Sitagliptin Phosphate | 23 | $27K |
| Linagliptin | 39 | $26K |
| Insulin Aspart Prot/Insuln Asp | 25 | $26K |
| Dapagliflozin Propanediol | 16 | $24K |
| Insulin Degludec | 31 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 30 | $19K |
| Budesonide/Formoterol Fumarate | 27 | $18K |
Prescribing Profile
Patient Profile
74
Avg Age
61%
Female
1.19
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About